Despite several papers that mentioned a special role of RXRα receptor in resistance mechanisms, maximum resistance to retinoic acid was shown in ovarian cancer cell lines with downregulation of both RARα and RXRα in contrast to cell lines with reduced levels of either RARα alone or RXRα alone [60]. The gene discussed is RARA; the disease is ovarian cancer.